【映恩生物高开超90% 昨日暗盘迎来大涨】截至发稿,映恩生物(09606.HK)涨91.33%。消息方面,该公司在昨日的暗盘大涨87.1%。根据公开资料,映恩生物是一家专注于新一代抗体偶联药物研发的创新生物制药企业,致力于为癌症和自身免疫性疾病等患者研发新一代ADC创新药物。

金融界
15 Apr
截至发稿,映恩生物(09606.HK)涨91.33%。消息方面,该公司在昨日的暗盘大涨87.1%。根据公开资料,映恩生物是一家专注于新一代抗体偶联药物研发的创新生物制药企业,致力于为癌症和自身免疫性疾病等患者研发新一代ADC创新药物。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10